Delaware
|
0-22710
|
13-3673965
|
(State
or other jurisdic-
|
(Commission
|
(IRS
Employer
|
tion
of incorporation)
|
File
Number)
|
Identification
No.)
|
75
Adams Avenue, Hauppauge, New York
|
11788
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Item 3.01 |
Notice
of Failure to Satisfy a Continued Listing
Rule
|
1.
|
Section
1003(a)(i) because of stockholders equity less than $2,000,000 and
losses
from continuing operations and net losses in two out of its three
most
recent fiscal years;
|
2.
|
Section
1003(a)(ii) because of stockholders equity of less than $4,000,000
and
losses from continuing operations and net losses in three out of
its four
most recent fiscal years; and
|
3.
|
Section
1003(a)(iv) because of sustained losses.
|
Item
5.02
|
Departure
of Directors or principal Officers; Election of Directors, Appointment
of
Principal Officers
|
Item
9.01
|
Financial
Statements and Exhibits
|
Exhibit
99.1
|
Press
release, dated April 16, 2008.
|
INTERPHARM
HOLDINGS, INC.
|
||
April
16, 2008
|
By:
|
/s/
Peter Giallorenzo.
|
Peter
Giallorenzo
|
||
|
Chief
Financial Officer and
|
|
|
Chief
Operating Officer
|